Zimmer Biomet Holdings R&D decreased by 12.9% to $103.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.5%, from $110.60M to $103.40M. Over 4 years (FY 2021 to FY 2025), R&D shows relatively stable performance with a 1.3% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $165.00M | $93.80M | $96.00M | $96.90M | $99.40M | $101.70M | $108.00M | $110.40M | $118.10M | $116.90M | $113.30M | $107.90M | $109.40M | $111.60M | $108.50M | $110.60M | $113.30M | $115.90M | $118.70M | $103.40M |
| QoQ Change | — | -43.2% | +2.3% | +0.9% | +2.6% | +2.3% | +6.2% | +2.2% | +7.0% | -1.0% | -3.1% | -4.8% | +1.4% | +2.0% | -2.8% | +1.9% | +2.4% | +2.3% | +2.4% | -12.9% |
| YoY Change | — | — | — | — | -39.8% | +8.4% | +12.5% | +13.9% | +18.8% | +14.9% | +4.9% | -2.3% | -7.4% | -4.5% | -4.2% | +2.5% | +3.6% | +3.9% | +9.4% | -6.5% |
Range$93.80M – $165.00M
CAGR-9.4%
Avg YoY Growth+1.8%
Median YoY Growth+3.7%
Geographic Breakdown
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Americas | $71.10M | $700.00K | $800.00K | $800.00K | $71.90M |
| Asia Pacific | $3.30M | $3.50M | $3.30M | $4.00M | $3.30M |
| EMEA | $2.10M | $2.50M | $2.50M | $2.70M | $1.70M |
| Total | $110.60M | $113.30M | $115.90M | $118.70M | $103.40M |
R&D at Other Companies
Frequently Asked Questions
- What is Zimmer Biomet Holdings's r&d?
- Zimmer Biomet Holdings (ZBH) reported r&d of $103.40M in Q1 2026.
- How has Zimmer Biomet Holdings's r&d changed year-over-year?
- Zimmer Biomet Holdings's r&d decreased by 6.5% year-over-year, from $110.60M to $103.40M.
- What is the long-term trend for Zimmer Biomet Holdings's r&d?
- Over 4 years (2021 to 2025), Zimmer Biomet Holdings's r&d has grown at a 1.3% compound annual growth rate (CAGR), from $435.80M to $458.50M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.